SIG BROKERAGE, LP
Broker-DealerPosition in GILD — Gilead Sciences, Inc.
CIK 1094429
BALA CYNWYD, PA
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,671,889
-$478,210 QoQ
Shares Held
52,809
+2.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#517
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIG BROKERAGE, LP holds $21,389,610 across 9 Drug Manufacturers - General names. GILD ranks #2 (31.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
67,374 | $8,657,559 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
52,809 | $6,671,889 | |
| 3 | LLY |
ELI LILLY & Co
|
1,487 | $1,783,552 | |
| 4 | BIIB |
Biogen Inc.
|
6,824 | $1,474,393 | |
| 5 | PFE |
Pfizer Inc
|
52,022 | $1,252,689 | |
| 6 | JNJ |
Johnson & Johnson
|
2,095 | $532,067 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,817 | $508,035 | |
| 8 | AMGN |
Amgen Inc
|
768 | $278,108 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,671,889 | 52,809 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,150,099 | 51,303 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,370,206 | 51,900 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,780,658 | 52,078 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,043,856 | 54,513 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||